|
|
|
|
LEADER |
03531nam a2200625Ia 4500 |
001 |
10.1016-j.jpha.2020.05.014 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 20951779 (ISSN)
|
245 |
1 |
0 |
|a Antimicrobial activity and mode of action of terpene linalyl anthranilate against carbapenemase-producing Klebsiella pneumoniae
|
260 |
|
0 |
|b Xi'an Jiaotong University
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jpha.2020.05.014
|
520 |
3 |
|
|a Mining of plant-derived antimicrobials is the major focus at current to counter antibiotic resistance. This study was conducted to characterize the antimicrobial activity and mode of action of linalyl anthranilate (LNA) against carbapenemase-producing Klebsiella pneumoniae (KPC-KP). LNA alone exhibited bactericidal activity at 2.5% (V/V), and in combination with meropenem (MPM) at 1.25% (V/V). Comparative proteomic analysis showed a significant reduction in the number of cytoplasmic and membrane proteins, indicating membrane damage in LNA-treated KPC-KP cells. Up-regulation of oxidative stress regulator proteins and down-regulation of oxidative stress-sensitive proteins indicated oxidative stress. Zeta potential measurement and outer membrane permeability assay revealed that LNA increases both bacterial surface charge and membrane permeability. Ethidium bromide influx/efflux assay showed increased uptake of ethidium bromide in LNA-treated cells, inferring membrane damage. Furthermore, intracellular leakage of nucleic acid and proteins was detected upon LNA treatment. Scanning and transmission electron microscopies again revealed the breakage of bacterial membrane and loss of intracellular materials. LNA was found to induce oxidative stress by generating reactive oxygen species (ROS) that initiate lipid peroxidation and damage the bacterial membrane. In conclusion, LNA generates ROS, initiates lipid peroxidation, and damages the bacterial membrane, resulting in intracellular leakage and eventually killing the KPC-KP cells. © 2020 Xi'an Jiaotong University
|
650 |
0 |
4 |
|a anthranilic acid derivative
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a bacterial membrane
|
650 |
0 |
4 |
|a bacterial outer membrane
|
650 |
0 |
4 |
|a bacterial protein
|
650 |
0 |
4 |
|a bactericidal activity
|
650 |
0 |
4 |
|a bactericide
|
650 |
0 |
4 |
|a carbapenemase producing Enterobacteriaceae
|
650 |
0 |
4 |
|a Comparative proteomic
|
650 |
0 |
4 |
|a comparative proteomics
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a cytoplasm protein
|
650 |
0 |
4 |
|a down regulation
|
650 |
0 |
4 |
|a drug uptake
|
650 |
0 |
4 |
|a ethidium bromide
|
650 |
0 |
4 |
|a Klebsiella pneumoniae
|
650 |
0 |
4 |
|a KPC-KP
|
650 |
0 |
4 |
|a Linalyl anthranilate
|
650 |
0 |
4 |
|a lipid peroxidation
|
650 |
0 |
4 |
|a membrane damage
|
650 |
0 |
4 |
|a Membrane damage
|
650 |
0 |
4 |
|a membrane permeability
|
650 |
0 |
4 |
|a membrane protein
|
650 |
0 |
4 |
|a meropenem
|
650 |
0 |
4 |
|a minimum inhibitory concentration
|
650 |
0 |
4 |
|a nonhuman
|
650 |
0 |
4 |
|a nucleic acid
|
650 |
0 |
4 |
|a oxidative stress
|
650 |
0 |
4 |
|a reactive oxygen metabolite
|
650 |
0 |
4 |
|a regulator protein
|
650 |
0 |
4 |
|a ROS
|
650 |
0 |
4 |
|a surface charge
|
650 |
0 |
4 |
|a terpene derivative
|
650 |
0 |
4 |
|a transmission electron microscopy
|
650 |
0 |
4 |
|a upregulation
|
650 |
0 |
4 |
|a zeta potential
|
700 |
1 |
|
|a Ajat, M.
|e author
|
700 |
1 |
|
|a Lai, K.-S.
|e author
|
700 |
1 |
|
|a Lim, S.-H.E.
|e author
|
700 |
1 |
|
|a Yang, S.-K.
|e author
|
700 |
1 |
|
|a Yap, W.-S.
|e author
|
700 |
1 |
|
|a Yusoff, K.
|e author
|
773 |
|
|
|t Journal of Pharmaceutical Analysis
|